All PlansAdministrativeMedium impact
Recall: Tirosint
UPMC Health Plan·Endocrinology, Family Medicine, Internal Medicine +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
IBSA Pharma Inc. has recalled 27 lots of TIROSINT-SOL (levothyroxine sodium) Oral Solution due to subpotency issues. This is a drug safety recall affecting patients prescribed this specific thyroid medication formulation.
Action Required
Immediately: Clinical staff should identify patients prescribed TIROSINT-SOL and check lot numbers against the recall list. Providers must contact affected patients to discontinue recalled lots and prescribe alternative thyroid medications. Update patient records to document medication changes and ensure continuity of thyroid hormone therapy.